DNA Hypermethylation of Myeloid Cells, A Novel Therapeutic Target in MDS and AML

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|7|5|315-321

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.7, Iss.5, 2006-01, pp. : 315-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 735-748

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS

By  

Current Cancer Drug Targets, Vol. 6, Iss. 6, 2006-09 ,pp. : 553-563

Bentham Science Publishers

Access to resources Recommend Favorite

Ectopic ATP Synthase in Endothelial Cells: A Novel Cardiovascular Therapeutic Target

By  

Current Pharmaceutical Design, Vol. 16, Iss. 37, 2010-12 ,pp. : 4074-4079

Bentham Science Publishers

Access to resources Recommend Favorite

The DNA Methylation Machinery as a Therapeutic Target

By  

Current Drug Targets, Vol. 1, Iss. 1, 2000-07 ,pp. : 101-118

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation

By  

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 215-225

Bentham Science Publishers

Access to resources Recommend Favorite